Skip to content

The Effects of Dignity Therapy on Dignity, Hope, Depression, and Treatment Adherence in Patients with End-Stage Renal Disease

The Effects of Dignity Therapy on Dignity, Hope, Depression, and Treatment Adherence in Patients with End-Stage Renal Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104449
Enrollment
Unknown
Registered
2025-06-17
Start date
2025-06-25
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-Stage Renal Disease

Interventions

Experimental group:Dignity therapy + conventional treatment
Control group:Conventional treatment

Sponsors

North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed end-stage renal disease, eGFR =18 years; 3. Able to understand the content of the intervention and the questionnaire items; 4. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient has a severe mental disorder (such as schizophrenia or bipolar disorder); 2. The patient has other serious physical diseases, and the life expectancy is < 3 months; 3. Have recently received or are participating in similar psychological interventions; 4. Presence of severe auditory or speech impairment that precludes completion of the intervention and assessment.

Design outcomes

Primary

MeasureTime frame
Patient Dignity Inventory Score, PDI;

Secondary

MeasureTime frame
Treatment Adherence Scale for Patients with End-Stage Renal Disease Score;Herth Hope Index Score, HHI;Patient Health Questionnaire-9 Score, PHQ-9;

Countries

China

Contacts

Public ContactChen Yinhai; Ke Xiong

North Sichuan Medical College

kexiong@126.com+86 135 1829 5995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026